This 2017 GMC Canyon in Vermilion, AB is available for a test drive today. This vehicle also has the following features: Single Zone Automatic Air Conditioning, Rear View Camera, Remote Engine Start, Rear Sliding Window, Premium Sound System, Onstar, Heated Seats. To view and download a brochure open this url.

The high death rate of pancreatic cancer is attributed to the lack of reliable methods for early detection and underlying molecular mechanisms of its aggressive pathogenesis. Can Speed Cameras See The Driver. Although MUC13, a newly identified transmembrane mucin, is known to be aberrantly expressed in ovarian and gastro-intestinal cancers, its role in pancreatic cancer is unknown. Herein, we investigated the expression profile and functions of MUC13 in pancreatic cancer progression. The expression profile of MUC13 in pancreatic cancer was investigated using a recently generated monoclonal antibody (clone PPZ0020) and pancreatic tissue microarrays. The expression of MUC13 was significantly ( P.

Introduction In 2011, pancreatic cancer is estimated to be detected in more than 44,000 people and to account for more than 37,000 deaths in the United States (). With an overall 5-year survival rate of only 5%, pancreatic cancer is the fourth most lethal cancer, accounting for 6% of all cancer-related deaths in both men and women (). Together, the aggressive nature of pancreatic cancer combined with vague symptoms and lack of screening mechanisms create a difficult disease to treat. The serum tumor marker CA19-9 may be helpful in diagnosing pancreatic cancer, but it lacks sensitivity and specificity to effectively screen asymptomatic patients (). Therefore, the identification of sensitive and specific markers is needed for early detection and subsequent treatment of pancreatic cancer. Mucins (MUC) have been identified as potential tumor markers and attractive therapeutic targets (, ).

Mucins form a physical barrier which provides protection for epithelial cells under normal physiologic conditions. However, mucins may be involved in cancer development when expression, localization, or glycosylation patterns change. Such changes can lead to increased cell growth, transformation, and decreased immune surveillance (, ). Mucin 13 (MUC13) is a recently identified trans-membrane mucin which is normally expressed in the large intestine, trachea, kidney, small intestine, and gastric epithelium (, ). In recent studies, MUC13 has been shown to be aberrantly expressed in ovarian and gastrointestinal cancers (–). MUC13 has a large 151-amino acid tandem repeat domain, 3 epidermal growth factor (EGF)-like domains, and a sea urchin sperm protein enterokinase arginine (SEA) domain within the extracellular component, followed by a short 23-amino acid trans-membrane domain and a 69-amino acid cytoplasmic domain (). In this study, we show that MUC13 is overexpressed in pancreatic cancer and the exogenous expression of MUC13 augments tumorigenic features in pancreatic cancer cells, such as enhanced cell proliferation, cell motility, cell invasion, and in vivo tumor growth.

Conversely, the suppression of MUC13 expression by short hairpin RNA (shRNA) in HPAFII cells shows the opposite effect. Boondocks The Fundraiser Mp4 Download. The expression of MUC13 correlates with the expression/activation of HER2, PAK1, ERK, Akt, and S100A4 and the decreased expression of p53. These results show, for the first time, the direct association of MUC13 with pancreatic cancer and its influence on pancreatic tumorigenesis. Cell culture, transfection procedure, and reagents Human pancreatic cancer cells procured from American Type Cell Culture Collection were maintained at 37°C in recommended growth medium (MiaPaca:DMEM, HPAFII:DMEM/Ham’s F12) supplemented with 10% FBS and antibiotics (Hyclone Laboratories). To maintain authenticity of the cell lines, frozen stocks were prepared from initial stocks and every 6 months a new frozen stock was used for the experiments.